Clinical Trial Update: The Effects of Lactobacillus Reuteri DSM 17938 on Immunomodulation and Gastric Motility in Preterm Newborns [EARLY_Phase 1]

View source ↗

Summary

Completed early-phase 1 trial evaluating the effects of Lactobacillus reuteri DSM 17938 on immunomodulation and gastric motility in preterm newborns.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preterm Birth

Drugs mentioned

• Lactobacillus reuteri DSM 17938 (Lactobacillus reuteri DSM 17938)

Snippet

Sponsor: University of Bari | Conditions: Preterm Birth | EARLY_Phase 1 | Status: COMPLETED